| Recruiting | 3 | 390 | Europe, RoW | Trimodulin, BT588, Placebo (human albumin 1%) | Biotest | Respiratory Infection, Pneumonia, Community-acquired Pneumonia, Acute Respiratory Distress Syndrome, COVID-19, Viral Pneumonia, Bacterial Pneumonia, Fungal Pneumonia | 08/25 | 08/25 | | |
TREAT-HAP, NCT05914584: "Baricitinib for Treating Hospital-acquired Pneumonia in Critically Ill Patients With a Proinflammatory Phenotype. |
|
|
| Not yet recruiting | 3 | 450 | Europe | Baricitinib 4 MG | Nantes University Hospital | Hospital-acquired Pneumonia | 08/25 | 12/25 | | |
NCT03083652: Effects of Neuromuscular Electrical Stimulation on Exercise Capacity in Respiratory Critically Ill Patients |
|
|
| Recruiting | N/A | 40 | Europe | Neuromuscular electrical stimulation, Sham | Hospital Clinic of Barcelona | Critical Illness Myopathy | 06/24 | 06/24 | | |
NCT03083652: Effects of Neuromuscular Electrical Stimulation on Exercise Capacity in Respiratory Critically Ill Patients |
|
|
| Recruiting | N/A | 40 | Europe | Neuromuscular electrical stimulation, Sham | Hospital Clinic of Barcelona | Critical Illness Myopathy | 06/24 | 06/24 | | |
